GFAP and central nervous system cancer: In accordance, we found that PAP-1 treatment in glioma-bearing mice significantly decreased peritumoral staining with GFAP (Fig. 2h), confirming that the increased glutamate transporter activity induced by Kv1.3 inhibition correlates with the reduction of astrogliosis.